Status:
COMPLETED
Ubiquinone (Coenzyme Q10) Application After Gingival Recession Coverage
Lead Sponsor:
University of Bern
Conditions:
Gingival Recession
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomised double blinded clinical trial has the aim to assess the effect of ubiquinone (Coenzyme Q10) on early wound healing following gingival recession coverage. Coenzyme Q10 (CoQ10) is a crit...
Detailed Description
Gingival recessions constitute a common problem in the adult population worldwide. In the United States the prevalence of ≥1 mm recession in persons \>30 years was 58%, representing over 60 million ad...
Eligibility Criteria
Inclusion
- Patients with single and multiple Miller class I, II and III gingival recessions will be included
- Written informed consent
Exclusion
- Patients with a history of chronic inflammatory disease
- Patients with severe systemic diseases
- Patients with any sign of clinical infection
- Patients smoking \> 5 cigarettes
- Pregnant or lactating women
- Patients \< 18 years of age
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04487652
Start Date
September 1 2020
End Date
January 31 2023
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Periodontology
Bern, Switzerland, 3010